EVA; A novel therapeutic targeting Rationale for the Treatment of Glioblastoma.

被引：0
|
作者：
Rusch, Tillmann [1 ]
Zhao, Kai [2 ]
Neubauer, Andreas [1 ]
Nimsky, Christopher [2 ]
Bartsch, Joerg [2 ]
机构：
[1] UKGM Giessen & Marburg, Standort Marburg, Klin Hamatol Onkol & Immunol, Marburg, Germany
[2] UKGM Giessen & Marburg, Standort Marburg, Klin Neurochirurgie, Marburg, Germany
来源：
INNERE MEDIZIN | 2024年 / 65卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
P16-10
引用
收藏
页码：S113 / S113
页数：1
相关论文
共 50 条
  • [41] Therapeutic potential of natural products in glioblastoma treatment: targeting key glioblastoma signaling pathways and epigenetic alterations
    Abbas, M. N.
    Kausar, S.
    Cui, H.
    CLINICAL & TRANSLATIONAL ONCOLOGY, 2020, 22 (07): : 963 - 977
  • [42] Therapeutic potential of natural products in glioblastoma treatment: targeting key glioblastoma signaling pathways and epigenetic alterations
    M. N. Abbas
    S. Kausar
    H. Cui
    Clinical and Translational Oncology, 2020, 22 : 963 - 977
  • [43] Causes of drug resistance and novel therapeutic opportunities for the treatment of glioblastoma
    Nagane, M
    Huang, HJS
    Cavenee, WK
    DRUG RESISTANCE UPDATES, 1999, 2 (01) : 30 - 37
  • [44] Implication of DYRK1B kinase in dormant glioblastoma cancers and utilization of DYRK1B inhibitors as a novel therapeutic strategy for glioblastoma.
    Vilenchik, Maria
    Kuznetsova, Alexandra
    Frid, Michael
    Duey, Menelik
    Damiani, Arianna
    De Leon, Lita
    Law, Jason
    Golbin, Denis A.
    Shishkina, Ludmila V.
    Potapova, Olga
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)
  • [45] The search for novel therapeutic strategies in the treatment of recurrent glioblastoma multiforme
    Bambury, Richard M.
    Morris, Patrick G.
    EXPERT REVIEW OF ANTICANCER THERAPY, 2014, 14 (08) : 955 - 964
  • [46] LY500307 as a novel therapeutic agent for treatment of glioblastoma
    Sareddy, Gangadhara R.
    Gruslova, Aleksandra
    Cavazos, David A.
    Tekmal, Rajeshwar R.
    Brenner, Andrew J.
    Vadlamudi, Ratna K.
    CANCER RESEARCH, 2015, 75
  • [47] A novel MGMT methylation-based prognostic score in patients with glioblastoma.
    Gerratana, Lorenzo
    Lombardi, Giuseppe
    De Carlo, Elisa
    Buoro, Vanessa
    De Maglio, Giovanna
    Marcato, Raffaella
    Isola, Miriam
    Cattaneo, Monica
    Bellu, Luisa
    Pelizzari, Giacomo
    Gurrieri, Lorena
    Follador, Alessandro
    Puglisi, Fabio
    Pizzolitto, Stefano
    Fasola, Gianpiero
    Zagonel, Vittorina
    Rizzato, Simona
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35
  • [48] Therapeutic Potential of Thymoquinone in Glioblastoma Treatment: Targeting Major Gliomagenesis Signaling Pathways
    Chowdhury, Fabliha Ahmed
    Hossain, Md Kamal
    Mostofa, A. G. M.
    Akbor, Maruf Mohammad
    Bin Sayeed, Muhammad Shahdaat
    BIOMED RESEARCH INTERNATIONAL, 2018, 2018
  • [49] Targeting the DNA damage response in combination with high Z metal nanoparticle radiosensitizers in glioblastoma.
    Kerr, Brianna
    CANCER RESEARCH, 2021, 81 (13)
  • [50] Targeting the interleukin 10 receptor complex using a transmembrane targeting peptide to control microglia / macrophage polarisation in glioblastoma.
    Kuntzel, T.
    Spenle, C.
    Van der Heyden, M.
    Bagnard, D.
    GLIA, 2021, 69 : E556 - E557
12345